1. Market Research
  2. > Healthcare Market Trends
  3. > Diagnostics

Medical Diagnostics Industry Overview: Latest Market Reports & Studies

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
13 votes

Global Diagnostics Industry

The diagnostics industry involves testing patients to detect disease. Diagnosis can be used in the case of patients already presenting symptoms of disease, to screen asymptomatic patients as a matter of routine, and to allow ongoing testing in patients with disease to establish prognosis or check progress of therapy. The section is part of the wider healthcare industry.

The market can be broadly divided into:

  1. In vitro diagnostics (IVD), which refers to testing samples of blood, tissue, for example electrocardiography; and
  2. Diagnostic imaging, such as x-rays, computerized axial tomography (CAT), mammograms and magnetic resonance imaging (MRI).

Leading Market Segment

The IVD market, estimated at $44 billion in 2010, is predicted to reach $52 billion by 2013 with a compound annual grown rate of approximately 5%, according to research from RNCOS. A particularly profitable growth sector within IVD, molecular diagnostics is predicted to reach $15 billion by 2014 at a compound annual growth rate of just under 20% reports Renub Research. Infectious diseases account for more than a fifth of this segment, followed by oncology testing. By 2014 blood testing and genetic screening together will account for over a quarter of the market, with the US representing $6 billion of the molecular diagnostics market by that time.

Blood grouping reagent Export

Diagnostics Industry Regional Market Share

The In Vitro Diagnostic market is dominated by the US and the EU, which combined comprise about three quarters of the global market. This is because developed countries are witnessing a proliferation of diet and lifestyle related diseases such as cancer, diabetes and cardiovascular disease, whereas developing countries are more concerned with the diagnosis of infection and infectious disease.

In the lead, the IVD market in the US is forecast to grow 5.4% annually, reaching $23 billion in 2013. According to Global Industry Analysts, the US molecular diagnostics market will be over $6.35 billion by 2015.

Following behind, the EU represents the second-largest regional market, with its infectious-disease testing market estimated to reach $1.02 billion in 2012. There is strong growth in oncology testing and pharmacogenomics, which are predicted to show a compound annual growth rate of 10.71% and 11.05%, respectively, between 2011 and 2015.

Top 3 Medical Diagnostics Players

Roche is the market leader in IVD, holding approximately 20% of total market share, followed by Abbott and Siemens, each holding more than 10%.

Roche’s 20% market share represents yearly sales of $44 billion, with key products such as CoaguChek and Accu-Chek fueling the company’s growth. Roche saw 20% growth in Asia-Pacific alone and a 5% rise in the US. Acquisitions, such as in diabetes care (Medingo Ltd) and tissue diagnostics (Biolmagene Inc), should see continued market growth for Roche going forward.

In business for over 120 years, Abbott's sales in 2010 reached over $35 billion, and it invested $3.7 billion in R&D. Its main area of expertise in diagnostics is immunodiagnostics. Abbott's immunoassay diagnostic systems, AxSYM, is used to test for cardiovascular disease, cancer, infectious diseases and thyroid conditions.

Read more »

Share
24/7 Customer Support

Talk to Sam

09 71 09 10 32

1-10 of about 1400 reports

Global Diagnostics Industry

  • November 2016
    36 pages
  • Diagnostics  

    Infectious Dise...  

    Immunochemistry...  

  • Europe  

    World  

View report >

The future of the Diagnostics Industry in the US

  • June 2017
    14 pages
  • Diagnostics  

  • United States  

    United Kingdom  

View report >

Diagnostics Forecast Statistics in Europe

  • February 2015
    96 pages
  • Europe  

    World  

View report >

Diagnostics Industry in the UK

  • June 2017
    9 pages
  • Diagnostics  

  • United Kingdom  

View report >

Diagnostics Industry in China

  • March 2017
    8 pages
  • China  

    Saudi Arabia  

    Asia  

View report >

Diagnostics Industry in South Africa

  • September 2016
    8 pages
  • Diagnostics  

  • South Africa  

    United States  

View report >

Diagnostics Industry in India - Forecast

  • June 2017
    2 pages
  • Diagnostics  

    Laboratory  

    Healthcare  

  • India  

    Asia  

View report >

The future of the Pharmaceutical Industry in India

  • June 2017
    3 pages
  • Pharmaceutical  

    Laboratory  

  • India  

    Asia  

    Germany  

View report >

Influenza Statistics in Australia

  • June 2017
    9 pages
  • Influenza  

    Hospital  

    Dysfunction Dru...  

  • Australia  

    World  

View report >

Biopsy Industry in the UK

  • June 2017
    10 pages
  • Hospital  

    Mortality  

    Biopsy  

  • United Kingdom  

View report >


About 4700 reports

Purchase Reports From Reputable Market Research Publishers
(From € 135 - € 19182)

Global Tumor Markers Testing Market 2021: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Seggment Forecasts, Emerging Tests, Technologies and Opportunities

  • € 19182
  • Industry report
  • June 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Global Cancer Diagnostics Market Analysis 2021: Usa, Eu ...

June 2017 € 19182

Cancer Diagnostics 2021: Supplier Shares And Strategies ...

March 2017 € 19182

2017 Tumor Markers: Supplier Shares By Test, Competitiv ...

March 2017 € 19182

Asia-pacific Infectious Disease Testing Market 2021: A ...

May 2017 € 15273

World Molecular Diagnostic Analyzers And Reagents Marke ...

June 2017 € 14455

Asia-pacific Virology And Bacteriology Testing Market 2 ...

June 2017 € 12455

Europe Automated Microbiology Market 2021: France, Germ ...

June 2017 € 11727

Europe Tumor Markers Testing Market 2021: France, Germa ...

June 2017 € 11636

2017 Europe Tumor Markers: Supplier Shares By Test, Com ...

March 2017 € 11636

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.